New inhaler device tested for safety in major COPD trial

NCT ID NCT05573464

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study compared the safety of a new inhaler device (HFO) to a standard one (HFA) for delivering the same triple-combination COPD medication. It involved 559 adults with moderate to very severe COPD over 12 weeks, with some continuing for a year. The main goal was to see if the new device caused similar or fewer side effects than the one already in use.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Phoenix, Arizona, 85032, United States
Research Site

Newport Beach, California, 92663, United States
Research Site

Miami, Florida, 33175, United States
Research Site

Sarasota, Florida, 34239, United States
Research Site

Tampa, Florida, 33606, United States
Research Site

Valparaiso, Indiana, 46383, United States
Research Site

Crowley, Louisiana, 70526, United States
Research Site

North Dartmouth, Massachusetts, 02747, United States
Research Site

St Louis, Missouri, 63141, United States
Research Site

Charlotte, North Carolina, 28209, United States
Research Site

Wilmington, North Carolina, 28401, United States
Research Site

Dublin, Ohio, 43016, United States
Research Site

Grants Pass, Oregon, 97527, United States
Research Site

Portland, Oregon, 97202, United States
Research Site

Anderson, South Carolina, 29621, United States
Research Site

Columbia, South Carolina, 29204, United States
Research Site

Gaffney, South Carolina, 29340, United States
Research Site

Longview, Texas, 75605, United States
Research Site

McKinney, Texas, 75069, United States
Research Site

Richmond, Virginia, 23219, United States
Research Site

Buenos Aires, C1414AIF, Argentina
Research Site

Buenos Aires, C1425BEN, Argentina
Research Site

Quilmes, B1878FNR, Argentina
Research Site

Rosario, S2000DEJ, Argentina
Research Site

San Fernando, B1646EBJ, Argentina
Research Site

Blagoevgrad, 2700, Bulgaria
Research Site

Dupnitsa, 2602, Bulgaria
Research Site

Lom, 3600, Bulgaria
Research Site

Pernik, 2300, Bulgaria
Research Site

Sandanski, 2800, Bulgaria
Research Site

Sevlievo, 5400, Bulgaria
Research Site

Sofia, 1618, Bulgaria
Research Site

Veliko Tarnovo, 5000, Bulgaria
Research Site

Vidin, 3700, Bulgaria
Research Site

Truro, Nova Scotia, B2N 1L2, Canada
Research Site

Ajax, Ontario, L1S 2J5, Canada
Research Site

Burlington, Ontario, L7N 3V2, Canada
Research Site

Guelph, Ontario, N1H 6J2, Canada
Research Site

Montreal, Quebec, H1Y 3H5, Canada
Research Site

Québec, Quebec, G1G 3Y8, Canada
Research Site

Québec, Quebec, G1V 4G5, Canada
Research Site

Québec, Quebec, G2J 0C4, Canada
Research Site

Saint-Charles-Borromée, Quebec, J6E 2B4, Canada
Research Site

Trois-Rivières, Quebec, G8T 7A1, Canada
Research Site

Berlin, 10629, Germany
Research Site

Berlin, 10787, Germany
Research Site

Berlin, 10969, Germany
Research Site

Berlin, 12159, Germany
Research Site

Berlin, 13156, Germany
Research Site

Dresden, 01069, Germany
Research Site

Elsterwerda, 04910, Germany
Research Site

Essen, 45359, Germany
Research Site

Halle, 06108, Germany
Research Site

Hamburg, 20253, Germany
Research Site

Hanover, 30159, Germany
Research Site

Hanover, 30449, Germany
Research Site

Hanover, D-30173, Germany
Research Site

Karlsruhe, 76137, Germany
Research Site

Koblenz, 56068, Germany
Research Site

Magdeburg, 39120, Germany
Research Site

Rheine, 48431, Germany
Research Site

Schwerin, 19055, Germany
Research Site

Wiesbaden, 65189, Germany
Research Site

Witten, 58452, Germany
Research Site

Cuernavaca, 62290, Mexico
Research Site

Culiacán, 80200, Mexico
Research Site

Mérida, 97130, Mexico
Research Site

México, 03300, Mexico
Research Site

Monterrey, 64020, Mexico
Research Site

Będzin, 42-500, Poland
Research Site

Bydgoszcz, 85-231, Poland
Research Site

Grodzisk Mazowiecki, 05-825, Poland
Research Site

Inowrocław, 88-100, Poland
Research Site

Jelenia Góra, 58-506, Poland
Research Site

Krakow, 31-011, Poland
Research Site

Lodz, 91-053, Poland
Research Site

Lublin, 20-412, Poland
Research Site

Piaseczno, 05-500, Poland
Research Site

Skórzewo, 60-185, Poland
Research Site

Szczecin, 70-111, Poland
Research Site

Zamość, 22-400, Poland
Research Site

Ankara, 06620, Turkey (Türkiye)
Research Site

Istanbul, 34020, Turkey (Türkiye)
Research Site

Izmir, 35110, Turkey (Türkiye)
Research Site

Mersin, 33343, Turkey (Türkiye)
Research Site

Pamukkale, 20070, Turkey (Türkiye)
Research Site

Blackpool, FY3 7EN, United Kingdom
Research Site

Corby, NN17 2UR, United Kingdom
Research Site

Liverpool, L1 9ED, United Kingdom
Research Site

Poole, BH15 2HX, United Kingdom
Research Site

Thetford, IP24 1JD, United Kingdom

Conditions

Explore the condition pages connected to this study.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)